{
    "clinical_study": {
        "@rank": "13149", 
        "arm_group": [
            {
                "arm_group_label": "Fluoride Varnish", 
                "arm_group_type": "Experimental", 
                "description": "Fluoride varnish was used once in this group. Fluoride varnish(NaF 5%,Sultan,USA)"
            }, 
            {
                "arm_group_label": "Oral hygiene", 
                "arm_group_type": "Experimental", 
                "description": "Oral hygiene followed twice daily. No F varnish or CPP-ACP applied."
            }, 
            {
                "arm_group_label": "CPP-ACP", 
                "arm_group_type": "Experimental", 
                "description": "CPP-ACP paste (GC Tooth Mousse,Gc,USA)was applied by patients once daily. 3gr,for 42 days."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study was to investigate the effect of Fluoride varnish and Casein\n      Phospho-Peptide Amorphous Calcium Phosphate (CPP-ACP) containing paste on oral symptoms and\n      salivary characteristics in patients under chemotherapy."
        }, 
        "brief_title": "Effect of Fluoride Varnish and CPP-ACP on Oral and Salivary Symptoms During Chemotherapy", 
        "completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "condition": [
            "Mucositis", 
            "Dry Mouth", 
            "Infection"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Xerostomia", 
                "Mucositis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Chemotherapy as a treatment method of cancers, affects different parts of the oral cavity\n      such as oral mucosa, teeth and salivary glands caused by salivary glands dysfunction during\n      chemotherapy.Oral status of patients under chemotherapy will be affected by consumption of\n      the drugs and their side effects such as reduction of the saliva, dryness of the oral\n      cavity, changes in bacterial balance, oral mucosa damage, bleeding due to irritation of the\n      tissues, xerostomia, dental caries, burning sensation, dysgeusia and dysphagia. No effective\n      preventive protocol has been presented for oral care during chemotherapy.\n\n      Patients who were met the inclusion criteria (aged over 12, diagnosed to have cancer by an\n      oncologists and needed chemotherapy drugs, had at least 20 teeth, had no other pathologic\n      lesion in their oral cavity, were not treated by radiotherapy and did not have specific\n      systemic diseases or head and neck cancer) were selected for the study. the participants\n      were evaluated according to oral and salivary symptoms."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  to have cancer (in the first stage of their treatments)\n\n          -  to have at least 20 teeth,\n\n          -  age over 12\n\n        Exclusion Criteria:\n\n          -  to have pathologic lesion in the oral cavity\n\n          -  being under radiotherapy\n\n          -  to have specific systemic diseases\n\n          -  to have head and neck cancer"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01737307", 
            "org_study_id": "AZadUMS"
        }, 
        "intervention": [
            {
                "arm_group_label": "Fluoride Varnish", 
                "description": "Fluoride Varnish (NaF 5%)", 
                "intervention_name": "Fluoride varnish", 
                "intervention_type": "Drug", 
                "other_name": "Fluoride varnish(NaF 5%,Sultan,USA)"
            }, 
            {
                "arm_group_label": "Oral hygiene", 
                "description": "Oral hygiene followed.", 
                "intervention_name": "Oral Hygiene", 
                "intervention_type": "Other", 
                "other_name": "Twice daily (tooth brush and tooth paste)."
            }, 
            {
                "arm_group_label": "CPP-ACP", 
                "description": "CPP-ACP paste was applied by patient, once daily.", 
                "intervention_name": "CPP-ACP", 
                "intervention_type": "Drug", 
                "other_name": [
                    "CPP-ACP Paste was used in this group.", 
                    "3 gr , once daily , 42 days."
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Fluorides, Topical", 
                "Fluorides"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Fluoride Varnish", 
            "CPP-ACP paste", 
            "Dry mouth", 
            "Burning sensation", 
            "Chemotherapy"
        ], 
        "lastchanged_date": "November 27, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tehran", 
                    "country": "Iran, Islamic Republic of"
                }, 
                "name": "Azad University of Medical Sciences, Dental Branch"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "3", 
        "official_title": "Effect of Fluoride Varnish and CPP-ACP Paste on Oral and Salivary Symptoms of Patients Under Chemotherapy: A Double-blind Clinical Trial", 
        "overall_official": {
            "affiliation": "Azad University of Medical Sciences, Dental Branch", 
            "last_name": "Sepideh Banava, Assist-Prof", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "oral symptoms(mucositis, xerostomia, infection, dysphagia, dysgeusia, burning sensation in mouth.", 
            "safety_issue": "No", 
            "time_frame": "6 weeks after first visit"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01737307"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Azad University of Medical Sciences", 
            "investigator_full_name": "Sepideh Banava.DDS,MS", 
            "investigator_title": "Assistant Professor Of Restorative Department", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "pH of saliva", 
                "safety_issue": "No", 
                "time_frame": "6 weeks after first visit"
            }, 
            {
                "measure": "pH of dental plaque", 
                "safety_issue": "No", 
                "time_frame": "6 weeks after first visit"
            }, 
            {
                "measure": "Quantity of saliva ( rest and stimulated)", 
                "safety_issue": "No", 
                "time_frame": "6 weeks after first visit"
            }, 
            {
                "measure": "Saliva buffering capacity", 
                "safety_issue": "No", 
                "time_frame": "6 weeks after first visit"
            }
        ], 
        "source": "Azad University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Azad University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}